Johnatty, SE, Tudini, E, Parsons, MT, Michailidou, K, Zanti, M, Canson, DM, Davidson, AL, Berger, T, Rosti, RO, Kratz, CP, Kalb, R, McReynolds, LJ, Giri, N, Richardson, ME, Pesaran, T, Surrallés, J, Pujol, R, Vundinti, BR, George, M, Maxwell, KN, Nathanson, K, Domchek, S, Fiesco-Roa, MO, Frias, S, Garcia-de-Teresa, B, Jongmans, M, Lalani, S, Maiburg, M, Prescott, K, Robinson, R, Rajagopalan, S, Blok, LS, Temple, SEL, Tucker, K, Auerbach, AD, Cancio, MI, Kennedy, JA, MacMillan, ML, Tryon, R, Wagner, JE, Walsh, M, Boddicker, NJ, Hu, CL, Weitzel, JN, Dingemans, AJM, Hadler, J, Rotenberg, N, Ramadane-Morchadi, L, de la Hoya, M, James, P, Hansen, TV, Vreeswijk, MPG, Walker, LC, Sharan, SK, Easton, DF, Couch, F, Smogorzewska, A, Nelson, A, Ngeow, J, Tischkowitz, M, Gomez-Garcia, E, Spurdle, AB. BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes. AMERICAN JOURNAL OF HUMAN GENETICS. 2025; 112(12)DOI:10.1016/j.ajhg.2025.10.007. PMID:41172994. IF:8.100(Q1/1D).

García-Alfonso, P, Jimenez-Fonseca, P, Soto-Alsar, J, Baraibar, I, Santos, C, La Casta, A, Ghanem, I, Cortijo, G, Méndez, A, Pazo-Cid, R, Vera, R, Melián, M, Alcaide, J, Graña, B, Páez, D, Gallego, I, Lobo, M, Borregón, M, Montes, A, de Castro, E, Carmona-Bayonas, A, Aranda, E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. ONCOLOGIST. 2025; 30(8)DOI:10.1093/oncolo/oyae300. PMID:39550209. IF:4.200(Q2/3D).

García-Alfonso, P, Elez, E, Soto-Alsar, J, Páez, D, Fernández-Montes, A, Graña, B, Salud, A, Yubero, A, Gómez-España, MA, Macías, I, Quintero, G, López-López, C, Fernández-Rodríguez, T, Grávalos, C, González-Flores, E, Guix, M, Paredes, BG, Reina, JJ, Mowbray, JRR, Sastre, J, Aranda, E. Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial. ESMO Open. 2024; 9(12)DOI:10.1016/j.esmoop.2024.103986. PMID:39608305. IF:8.300(Q1/2D).

Aranha, MR, Montal, V, van den Brink, H, Pegueroles, J, Carmona-Iragui, M, Videla, L, Blesa, LM, Benejam, B, Arranz, J, Valldeneu, S, Barroeta, I, Fernández, S, Ribas, L, Alcolea, D, González-Ortiz, S, Bargalló, N, Biessels, GJ, Blesa, R, Lleó, A, Coutinho, AM, Leite, CC, Bejanin, A, Fortea, J. Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI. ALZHEIMERS & DEMENTIA. 2024; 20(6)DOI:10.1002/alz.13797. PMID:38644660. IF:11.100(Q1/1D).